Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04419584Phase 3Recruiting
A Phase 3 trial of modified qing-ying decoction in atopic dermatitis (AD), sponsored by The Chinese University of Hong Kong. Started Sep 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04419584.